ConductScience.org, home

Paper39304574

Chemokine Receptor 4-Targeted PET/CT with [68Ga]pentixather in Newly Diagnosed Multiple Myeloma: a Comparative Study with [68Ga]pentixafor PET/CT.

Yang Q and 4 others. Mol Imaging Biol, 2024. Cited by 2 papers, by iCite.

Cite this record

ConductScience Library. Chemokine Receptor 4-Targeted PET/CT with [68Ga]pentixather in Newly Diagnosed Multiple Myeloma: a Comparative Study with [68Ga]pentixafor PET/CT. Papers, record 39304574. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39304574

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Chemokine Receptor 4-Targeted PET/CT with [68Ga]pentixather in Newly Diagnosed Multiple Myeloma: a Comparative Study with [68Ga]pentixafor PET/CT.
PubMed
Journal
Mol Imaging Biol
PubMed
Year
2024
PubMed
Publication types
Journal Article, Comparative Study, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
2
iCite
Relative citation ratio, by iCite
0.32, provisional
iCite
Revised in PubMed
2026-11-01
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Yang QQiao
2Zhang FFujing
3Hao ZZhixin
4Zhuang JJunling
5Huo LLi

Source PubMed

Download CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Multiple MyelomaMajor topic
Positron Emission Tomography Computed TomographyMajor topic
Humans
Male
Female
Middle Aged
Aged
Aged, 80 and over
Peptides, Cyclic
Adult
Tumor Burden
Gallium Radioisotopes
Coordination Complexes

Source PubMed

Download CSV of topics

Grants9

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
Grant No. 2022-2-4013the Capital Health Development Scientific Research FundPubMed
2022-PUMCH-B-048National High Level Hospital Clinical Research FundingPubMed
XH-QN-012KNational High Level Hospital Clinical Research FundingPubMed
2022-PUMCH-D-001National High Level Hospital Clinical Research FundingPubMed
2016YFC0901500National Key Research and Development Program of ChinaPubMed
CIFMS-2021-I2M-1-025CAMS innovation fund for medical sciencePubMed
CIFMS-2021-I2M-1-002CAMS innovation fund for medical sciencePubMed
CIFMS-2021-I2M-1-003CAMS innovation fund for medical sciencePubMed
82071967National Natural Science Foundation of ChinaPubMed

Source PubMed

Download CSV of grants

References35

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
128744319[177Lu]pentixather: Comprehensive Preclinical Characterization of a First CXCR4-directed Endoradiotherapeutic Agent.Theranostics2017https://conductscience.org/library/papers/28744319PubMed
221900099Soft-tissue plasmacytomas in multiple myeloma: incidence, mechanisms of extramedullary spread, and treatment approach.J Clin Oncol2011https://conductscience.org/library/papers/21900099PubMed
318332230Multiple myeloma.Blood2008https://conductscience.org/library/papers/18332230PubMed
419443657F18-fluorodeoxyglucose positron emission tomography in the context of other imaging techniques and prognostic factors in multiple myeloma.Blood2009https://conductscience.org/library/papers/19443657PubMed
534413147Biokinetics and Dosimetry of 177Lu-Pentixather.J Nucl Med2022https://conductscience.org/library/papers/34413147PubMed
617119115Mechanisms of regulation of CXCR4/SDF-1 (CXCL12)-dependent migration and homing in multiple myeloma.Blood2007https://conductscience.org/library/papers/17119115PubMed
728042328[68Ga]Pentixafor-PET/CT for imaging of chemokine receptor CXCR4 expression in multiple myeloma - Comparison to [18F]FDG and laboratory values.Theranostics2017https://conductscience.org/library/papers/28042328PubMed
831776631Chemokine receptor-4 targeted PET/CT with 68Ga-Pentixafor in assessment of newly diagnosed multiple myeloma: comparison to 18F-FDG PET/CT.Eur J Nucl Med Mol Imaging2020https://conductscience.org/library/papers/31776631PubMed
935103762Diagnosis and Management of Multiple Myeloma: A Review.JAMA2022https://conductscience.org/library/papers/35103762PubMed
1015809451International staging system for multiple myeloma.J Clin Oncol2005https://conductscience.org/library/papers/15809451PubMed
1134727187How I treat high-risk multiple myeloma.Blood2022https://conductscience.org/library/papers/34727187PubMed
1222045705CXCR4-based imaging agents.J Nucl Med2011https://conductscience.org/library/papers/22045705PubMed
1335674738CXCR4-targeted theranostics in oncology.Eur J Nucl Med Mol Imaging2022https://conductscience.org/library/papers/35674738PubMed
1428432222Low expression of hexokinase-2 is associated with false-negative FDG-positron emission tomography in multiple myeloma.Blood2017https://conductscience.org/library/papers/28432222PubMed
1525439696International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma.Lancet Oncol2014https://conductscience.org/library/papers/25439696PubMed
1626564323First-in-Human Experience of CXCR4-Directed Endoradiotherapy with 177Lu- and 90Y-Labeled Pentixather in Advanced-Stage Multiple Myeloma with Extensive Intra- and Extramedullary Disease.J Nucl Med2016https://conductscience.org/library/papers/26564323PubMed
1725736399In vivo molecular imaging of chemokine receptor CXCR4 expression in patients with advanced multiple myeloma.EMBO Mol Med2015https://conductscience.org/library/papers/25736399PubMed
1828529638CXCR4-directed endoradiotherapy induces high response rates in extramedullary relapsed Multiple Myeloma.Theranostics2017https://conductscience.org/library/papers/28529638PubMed
1933918655Role and Therapeutic Targeting of SDF-1α/CXCR4 Axis in Multiple Myeloma.Cancers (Basel)2021https://conductscience.org/library/papers/33918655PubMed
2030850502Side Effects of CXC-Chemokine Receptor 4-Directed Endoradiotherapy with Pentixather Before Hematopoietic Stem Cell Transplantation.J Nucl Med2019https://conductscience.org/library/papers/30850502PubMed

See all 35 referencesDownload CSV of references

Cited by2

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.

PMIDTitleJournalYearIn PapersSource
42244984The CXCR4-targeted theranostics era: a comprehensive review of a decade of progress (2015-2025).Theranostics2026https://conductscience.org/library/papers/42244984PubMed
41760826[68Ga]Ga-Pentixafor PET/CT for Durie-Salmon PLUS staging and risk stratification in newly diagnosed multiple myeloma.Eur J Nucl Med Mol Imaging2026https://conductscience.org/library/papers/41760826PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39304574

GET https://conductscience.org/api/papers/v1/39304574/references?page=2